Aim: This study aims to investigate the clinical efficacy and safety of DR SKS Hair Growth Booster Serum – cocktail of micronutrients and multivitamins, in male and female patients with androgenic alopecia.
Background: Androgenic alopecia is frequently encountered in dermatological practice; however, there is a lack of approved treatment. At present, only three therapies have been approved for on-label use in androgenetic alopecia -minoxidil, finasteride, and lower-level laser therapy. Micronutrients are primary elements in the normal hair follicle cycle, and their role in androgenic alopecia is a growing matter of research nowadays.
Methods: We did a cross-sectional, multicentre, retrospective study across 5 hair clinic chains in India (Mumbai, Hyderabad, Jabalpur, Balaghat and Nagpur). Eligible participants were patients with a confirmed diagnosis of androgenic alopecia, aged 18 years or older and any gender. Each patient received DR SKS Hair Growth Booster Serum, 1 ml in volume, once a month by mesotherapy/dermaroller/dermapen. This therapy lasted six months in total. All patients were subjected to 60-second hair counts test (Comb test), hair pulled test, global photographic assessment, trichoscopy assessment, patient self-assessment questionnaire, and safety assessment at baseline and 6-month after the treatment.
Results: There was a significant reduction in hair fall with bulb (<0.0001) and without bulb (<0.0001) 6-month after the treatment vs baseline. There was a significant improvement in number of hairs removed per pull (<0.0001), global photographic assessment score (<0.0001), hair growth rate (<0.0001), follicular hair density (<0.0001), vellus hair density (<0.0001), and terminal hair density (<0.0001) 6-month after the treatment vs baseline. Majority of patients (98%) were satisfied with six months treatment of DR SKS Hair Growth Booster Serum. No major adverse events were reported during the study.
Conclusion: DR SKS Hair Growth Booster Serum was found to be a safe and effective treatment for androgenic alopecia, with 98% patient self-assessment score.Stuti Khare,
Elements of Aesthetics Clinics, Mumbai, India.
Please see the link here: https://stm.bookpi.org/RDMMS-V10/article/view/10674
No comments:
Post a Comment